MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |
RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
H3P40 |
|
H3 histone pseudogene 40
|
|
|
0.506 |
0.846 |
RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
PIK3R2 |
O00459
|
phosphoinositide-3-kinase regulatory subunit 2
|
Enzyme modulator
|
1.6E-02 |
0.551 |
0.808 |
SDHD |
O14521
|
succinate dehydrogenase complex subunit D
|
Transporter
|
0.34 |
0.472 |
0.885 |
SOCS1 |
O15524
|
suppressor of cytokine signaling 1
|
Enzyme modulator
|
0.59 |
0.445 |
0.808 |
CBFA2T2 |
O43439
|
CBFA2/RUNX1 partner transcriptional co-repressor 2
|
Transcription factor
|
1.00 |
0.615 |
0.654 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
CYB5R3 |
P00387
|
cytochrome b5 reductase 3
|
|
1.9E-04 |
0.638 |
0.654 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
GH1 |
P01241
|
growth hormone 1
|
Signaling
|
3.0E-02 |
0.373 |
0.923 |
EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
GYPA |
P02724
|
glycophorin A (MNS blood group)
|
|
1.1E-03 |
0.538 |
0.885 |
ALB |
P02768
|
albumin
|
Transporter
|
0.64 |
0.317 |
0.962 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
SERPINE1 |
P05121
|
serpin family E member 1
|
Enzyme modulator
|
4.4E-02 |
0.359 |
0.885 |
EDN1 |
P05305
|
endothelin 1
|
Signaling
|
0.46 |
0.380 |
0.846 |
KLK1 |
P06870
|
kallikrein 1
|
Enzyme
|
1.5E-04 |
0.533 |
0.769 |
BPGM |
P07738
|
bisphosphoglycerate mutase
|
|
2.1E-02 |
0.821 |
0.154 |
FH |
P07954
|
fumarate hydratase
|
Enzyme
|
8.8E-02 |
0.489 |
0.846 |
HCK |
P08631
|
HCK proto-oncogene, Src family tyrosine kinase
|
Kinase
|
2.0E-02 |
0.663 |
0.500 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |